267 related articles for article (PubMed ID: 30373212)
21. Synthesis of 3-[(N-carboalkoxy)ethylamino]-indazole-dione derivatives and their biological activities on human liver carbonyl reductase.
Berhe S; Slupe A; Luster C; Charlier HA; Warner DL; Zalkow LH; Burgess EM; Enwerem NM; Bakare O
Bioorg Med Chem; 2010 Jan; 18(1):134-41. PubMed ID: 19959367
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of indazole derivatives.
Claramunt RM; López C; López A; Pérez-Medina C; Pérez-Torralba M; Alkorta I; Elguero J; Escames G; Acuña-Castroviejo D
Eur J Med Chem; 2011 Apr; 46(4):1439-47. PubMed ID: 21334118
[TBL] [Abstract][Full Text] [Related]
23. A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective.
Mal S; Malik U; Mahapatra M; Mishra A; Pal D; Paidesetty SK
Drug Dev Res; 2022 Nov; 83(7):1469-1504. PubMed ID: 35971890
[TBL] [Abstract][Full Text] [Related]
24. Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors.
Li X; Chu S; Feher VA; Khalili M; Nie Z; Margosiak S; Nikulin V; Levin J; Sprankle KG; Tedder ME; Almassy R; Appelt K; Yager KM
J Med Chem; 2003 Dec; 46(26):5663-73. PubMed ID: 14667220
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening.
Liu J; Zhou J; He F; Gao L; Wen Y; Gao L; Wang P; Kang D; Hu L
Eur J Med Chem; 2020 Apr; 192():112189. PubMed ID: 32151834
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of novel 1
Liu J; Wen Y; Gao L; Gao L; He F; Zhou J; Wang J; Dai R; Chen X; Kang D; Hu L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):72-84. PubMed ID: 31682465
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer.
Chen X; Liu Y; Zhang L; Chen D; Dong Z; Zhao C; Liu Z; Xia Q; Wu J; Chen Y; Zheng X; Cai Y
Eur J Med Chem; 2021 Mar; 214():113219. PubMed ID: 33618175
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of indazole motifs and their medicinal importance: an overview.
Gaikwad DD; Chapolikar AD; Devkate CG; Warad KD; Tayade AP; Pawar RP; Domb AJ
Eur J Med Chem; 2015 Jan; 90():707-31. PubMed ID: 25506810
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity.
El-Damasy AK; Jin H; Seo SH; Bang EK; Keum G
Eur J Med Chem; 2020 Dec; 207():112710. PubMed ID: 32961435
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity.
Maggio B; Raimondi MV; Raffa D; Plescia F; Cascioferro S; Plescia S; Tolomeo M; Di Cristina A; Pipitone RM; Grimaudo S; Daidone G
Eur J Med Chem; 2011 Jan; 46(1):168-74. PubMed ID: 21130540
[TBL] [Abstract][Full Text] [Related]
31. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.
McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM
Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel azaindazole CCR1 antagonist clinical candidates.
Harcken C; Kuzmich D; Cook B; Mao C; Disalvo D; Razavi H; Swinamer A; Liu P; Zhang Q; Kukulka A; Skow D; Patel M; Patel M; Fletcher K; Sherry T; Joseph D; Smith D; Canfield M; Souza D; Bogdanffy M; Berg K; Brown M
Bioorg Med Chem Lett; 2019 Feb; 29(3):441-448. PubMed ID: 30595446
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3,3a,4,5,6,7-hexahydro-2H-indazoles.
Minu M; Thangadurai A; Wakode SR; Agrawal SS; Narasimhan B
Bioorg Med Chem Lett; 2009 Jun; 19(11):2960-4. PubMed ID: 19410452
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and insight into the structure-activity relationship of 1,3-disubstituted indazoles as novel HIF-1 inhibitors.
An H; Kim NJ; Jung JW; Jang H; Park JW; Suh YG
Bioorg Med Chem Lett; 2011 Nov; 21(21):6297-300. PubMed ID: 21937231
[TBL] [Abstract][Full Text] [Related]
35. Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation.
Claramunt RM; López C; Pérez-Medina C; Pérez-Torralba M; Elguero J; Escames G; Acuña-Castroviejo D
Bioorg Med Chem; 2009 Sep; 17(17):6180-7. PubMed ID: 19679481
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, pharmacological study and modeling of 7-methoxyindazole and related substituted indazoles as neuronal nitric oxide synthase inhibitors.
Collot V; Sopkova-de Oliveira Santos J; Schumann-Bard P; Colloc'h N; Mackenzie ET; Rault S
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):195-9. PubMed ID: 12943204
[TBL] [Abstract][Full Text] [Related]
37. Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studies.
Gerpe A; Aguirre G; Boiani L; Cerecetto H; González M; Olea-Azar C; Rigol C; Maya JD; Morello A; Piro OE; Arán VJ; Azqueta A; de Ceráin AL; Monge A; Rojas MA; Yaluff G
Bioorg Med Chem; 2006 May; 14(10):3467-80. PubMed ID: 16483783
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological activity of some 3-(pyrazol-1'-yl)indazole derivatives.
Cecchi L; Melani F; Filacchioni G; Tredici M
Farmaco Sci; 1984 Nov; 39(11):945-52. PubMed ID: 6440811
[TBL] [Abstract][Full Text] [Related]
39. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
[TBL] [Abstract][Full Text] [Related]
40. Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: Synthesis and biological evaluation.
Obaid Arhema Frejat F; Zhai H; Cao Y; Wang L; Mostafa YA; Gomaa HAM; Youssif BGM; Wu C
Bioorg Chem; 2022 Sep; 126():105922. PubMed ID: 35667253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
